1959
Founder Mr. Johnson Huang started the company Johnson Chemical Pharmaceutical Works in June
1961
Started construction of new plant at current manufacturing site in July and completed in July of 1962
1963
Technical corporation with Taisho Pharmaceutical Co., Ltd. and manufactured Opyrin
1964
Expanded manufacturing site
1966
Johnson Chemical Pharmaceutical Works Ltd. was founded with an initial capital of NT$720,000
1979
Accumulated capital amounts to NT$43,300,000
1980
JCP acquired the corporate office building at 31, Sec.4, San Ho Road,
San Chung District, New Taipei City
1986
Started the construction of a new GMP plant and finished in 1988
1988
GMP certified
2000
Accumulated capital amounts to NT$119,900,000
2003
JCP acquired current manufacturing site at 77, Sec.4, San Ho Road,
San Chung District, New Taipei City
2005
cGMP certified
2007
Change of corporate name to Johnson Chemical Pharmaceutical Works Co., Ltd.
2009
Accumulated capital amounts to NT$145,000,000
FSC (Financial Supervisory Commission) approves public offering of common stock
2010
Issued emerging stock with stock symbol: 4747
JCP is PIC/S GMP certified by TFDA (Taiwan Food and Drug Administration)
2012
Accumulated capital amounts to NT$180,000,000
2013
Cash capital increased by NT$27,000,000 with total accumulated capital amounting
IPO listed on Taipei Exchange
2014
Accumulated capital amounts to NT$258,187,500
2015
JCP acquired land in YiLan county
2019
JCP reinvested Pei Jin International Co., Ltd.
2020
JCP acquired land in San Chong District